tebipenem and Lung-Diseases

tebipenem has been researched along with Lung-Diseases* in 1 studies

Other Studies

1 other study(ies) available for tebipenem and Lung-Diseases

ArticleYear
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Bioactive forms of oral β-lactams were screened

    Topics: Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefuroxime; Humans; Lactams; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus

2022